EyePoint, Inc. (EYPT)
4.875
-0.44
(-8.36%)
USD |
NASDAQ |
Aug 24, 16:00
4.89
+0.02
(+0.31%)
After-Hours: 20:00
EyePoint Max Drawdown (5Y) : 93.95% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 93.95% |
| June 30, 2026 | 93.95% |
| May 31, 2026 | 93.95% |
| April 30, 2026 | 93.95% |
| March 31, 2026 | 93.95% |
| February 28, 2026 | 93.95% |
| January 31, 2026 | 93.95% |
| December 31, 2025 | 93.95% |
| November 30, 2025 | 93.95% |
| October 31, 2025 | 93.95% |
| September 30, 2025 | 93.95% |
| August 31, 2025 | 93.95% |
| July 31, 2025 | 93.95% |
| June 30, 2025 | 93.95% |
| May 31, 2025 | 93.95% |
| April 30, 2025 | 93.95% |
| March 31, 2025 | 93.95% |
| February 28, 2025 | 93.95% |
| January 31, 2025 | 93.95% |
| December 31, 2024 | 93.95% |
| November 30, 2024 | 93.95% |
| October 31, 2024 | 93.95% |
| September 30, 2024 | 93.95% |
| August 31, 2024 | 93.95% |
| July 31, 2024 | 93.95% |
| Date | Value |
|---|---|
| June 30, 2024 | 93.95% |
| May 31, 2024 | 93.95% |
| April 30, 2024 | 93.95% |
| March 31, 2024 | 93.95% |
| February 29, 2024 | 93.95% |
| January 31, 2024 | 93.95% |
| December 31, 2023 | 93.95% |
| November 30, 2023 | 93.95% |
| October 31, 2023 | 93.95% |
| September 30, 2023 | 93.95% |
| August 31, 2023 | 93.95% |
| July 31, 2023 | 93.95% |
| June 30, 2023 | 93.95% |
| May 31, 2023 | 93.95% |
| April 30, 2023 | 93.95% |
| March 31, 2023 | 93.95% |
| February 28, 2023 | 93.71% |
| January 31, 2023 | 93.71% |
| December 31, 2022 | 93.71% |
| November 30, 2022 | 92.28% |
| October 31, 2022 | 92.28% |
| September 30, 2022 | 92.28% |
| August 31, 2022 | 92.28% |
| July 31, 2022 | 92.28% |
| June 30, 2022 | 92.28% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Ocular Therapeutix, Inc. | 90.94% |
| Eli Lilly & Co. | 34.47% |
| Elanco Animal Health, Inc. | 78.00% |
| Amylyx Pharmaceuticals, Inc. | -- |
| Nuvation Bio, Inc. | 93.39% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -11.59 |
| Beta (5Y) | 1.765 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 142.7% |
| Historical Sharpe Ratio (5Y) | 0.0326 |
| Historical Sortino (5Y) | 0.1187 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 33.38% |